Promoting roles of KLF5 in myocardial infarction in mice involving microRNA-27a suppression and the following GFPT2/TGF-β/Smad2/3 axis activation

References

• Barquera S, Pedroza-Tobias A, Medina C, et al. Global overview of the epidemiology of atherosclerotic cardiovascular disease. Arch Med Res. 2015;46(5):328–338.
   PubMed Web of Science ®Google Scholar
• Montrief T, Davis WT, Koyfman A, et al. Mechanical, inflammatory, and embolic complications of myocardial infarction: an emergency medicine review. Am J Emerg Med. 2019;37(6):1175–1183.
   PubMed Web of Science ®Google Scholar
• Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). J Am Coll Cardiol. 2018;72(18):2231–2264.
   PubMed Web of Science ®Google Scholar
• Sun T, Dong YH, Du W, et al. The role of MicroRNAs in myocardial infarction: from molecular mechanism to clinical application. Int J Mol Sci. 2017;18(4):745.
   Web of Science ®Google Scholar
• Yang D, Yu J, Liu HB, et al. The long non-coding RNA TUG1-miR-9a-5p axis contributes to ischemic injuries by promoting cardiomyocyte apoptosis via targeting KLF5. Cell Death Dis. 2019;10(12):908.
   PubMedGoogle Scholar
• Diakiw SM, D’Andrea RJ, Brown AL. The double life of KLF5: opposing roles in regulation of gene-expression, cellular function, and transformation. IUBMB Life. 2013;65(12):999–1011.
   PubMed Web of Science ®Google Scholar
• Dong JT, Chen C. Essential role of KLF5 transcription factor in cell proliferation and differentiation and its implications for human diseases. Cell Mol Life Sci. 2009;66(16):2691–2706.
   PubMed Web of Science ®Google Scholar
• Gholamin S, Pasdar A, Khorrami MS, et al. The potential for circulating microRNAs in the diagnosis of myocardial infarction: a novel approach to disease diagnosis and treatment. Curr Pharm Des. 2016;22(3):397–403.
   PubMed Web of Science ®Google Scholar
• Cao A, Li X. Bilobalide protects H9c2 cell from oxygen-glucose-deprivation-caused damage through upregulation of miR-27a. Artif Cells Nanomed Biotechnol. 2019;47(1):2980–2988.
   PubMed Web of Science ®Google Scholar
• Zhang H, Jia Y, Cooper JJ, et al. Common variants in glutamine: fructose-6-phosphateamidotransferase 2 (GFPT2) gene are associated with type 2 diabetes, diabetic nephropathy, and increased GFPT2 mRNA levels. J Clin Endocrinol Metab. 2004;89(2):748–755.
   PubMed Web of Science ®Google Scholar
• Li X, Geng J, Chen Y, et al. Exposure to particulate matter induces cardiomyocytes apoptosis after myocardial infarction through NFkappaB activation. Biochem Biophys Res Commun. 2017;488(1):224–231.
   PubMed Web of Science ®Google Scholar
• Cahill TJ, Choudhury RP, Riley PR. Heart regeneration and repair after myocardial infarction: translational opportunities for novel therapeutics. Nat Rev Drug Discov. 2017;16(10):699–717.
   PubMed Web of Science ®Google Scholar
• Drosatos K, Pollak NM, Pol CJ, et al. Cardiac myocyte KLF5 regulates ppara expression and cardiac function. Circ Res. 2016;118(2):241–253.
   PubMed Web of Science ®Google Scholar
• Shindo T, Manabe I, Fukushima Y, et al. Kruppel-like zinc-finger transcription factor KLF5/BTEB2 is a target for angiotensin II signaling and an essential regulator of cardiovascular remodeling. Nat Med. 2002;8(8):856–863.
   PubMed Web of Science ®Google Scholar
• Ohara F, Nii A, Sakiyama Y, et al. Pathophysiological characteristics of dimethylnitrosamine-induced liver fibrosis in acute and chronic injury models: a possible contribution of KLF5 to fibrogenic responses. Dig Dis Sci. 2008;53(8):2222–2232.
   PubMed Web of Science ®Google Scholar
• Jose Corbalan J, Vatner DE, Vatner SF. Myocardial apoptosis in heart disease: does the emperor have clothes? Basic Res Cardiol. 2016;111(3):31.
   PubMed Web of Science ®Google Scholar
• Francis Stuart SD, De Jesus NM, Lindsey ML, et al. The crossroads of inflammation, fibrosis, and arrhythmia following myocardial infarction. J Mol Cell Cardiol. 2016;91:114–122.
   PubMed Web of Science ®Google Scholar
• Prabhu SD, Frangogiannis NG. The biological basis for cardiac repair after myocardial infarction: from inflammation to fibrosis. Circ Res. 2016;119(1):91–112.
   PubMed Web of Science ®Google Scholar
• Talman V, Ruskoaho H. Cardiac fibrosis in myocardial infarction-from repair and remodeling to regeneration. Cell Tissue Res. 2016;365(3):563–581.
   PubMed Web of Science ®Google Scholar
• Cavalcante GC, Schaan AP, Cabral GF, et al. A cell’s fate: an overview of the molecular biology and genetics of apoptosis. Int J Mol Sci. 2019;20(17):20.
   Web of Science ®Google Scholar
• Liu L, Chen G, Chen T, et al. si-SNHG5-FOXF2 inhibits TGF-beta1-induced fibrosis in human primary endometrial stromal cells by the Wnt/beta-catenin signalling pathway. Stem Cell Res Ther. 2020;11(1):479.
   PubMed Web of Science ®Google Scholar
• Yu YH, Zhang YH, Ding YQ, et al. MicroRNA-99b-3p promotes angiotensin II-induced cardiac fibrosis in mice by targeting GSK-3beta. Acta Pharmacol Sin. 2020.
   Web of Science ®Google Scholar
• Sanz-Rosa D, Garcia-Prieto J, Ibanez B. The future: therapy of myocardial protection. Ann N Y Acad Sci. 2012;1254(1):90–98.
   PubMedGoogle Scholar
• O’Brien PJ. Cardiac troponin is the most effective translational safety biomarker for myocardial injury in cardiotoxicity. Toxicology. 2008;245(3):206–218.
   PubMed Web of Science ®Google Scholar
• Ruiz De Sabando A, Wang C, He Y, et al. ML264, A novel small-molecule compound that potently inhibits growth of colorectal cancer. Mol Cancer Ther. 2016;15(1):72–83.
   PubMed Web of Science ®Google Scholar
• Wu K, Zhao Q, Li Z, et al. Bioinformatic screening for key mi RNAs and genes associated with myocardial infarction. FEBS Open Bio. 2018;8(6):897–913.
   PubMed Web of Science ®Google Scholar
• Zhang J, Qiu W, Ma J, et al. miR-27a-5p attenuates hypoxia-induced rat cardiomyocyte injury by inhibiting Atg7. Int J Mol Sci. 2019;20(10):2418.
   Web of Science ®Google Scholar
• Li Y, Ren S, Xia J, et al. EIF4A3-induced circ-BNIP3 aggravated hypoxia-induced injury of H9c2 cells by targeting miR-27a-3p/BNIP3. Mol Ther Nucleic Acids. 2020;19:533–545.
   PubMedGoogle Scholar
• Prasad P, Tiwari AK, Kumar KM, et al. Association analysis of ADPRT1, AKR1B1, RAGE, GFPT2 and PAI-1 gene polymorphisms with chronic renal insufficiency among Asian Indians with type-2 diabetes. BMC Med Genet. 2010;11(1):52.
   PubMedGoogle Scholar
• Weigert C, Friess U, Brodbeck K, et al. Glutamine:fructose-6-phosphate aminotransferase enzyme activity is necessary for the induction of TGF-beta1 and fibronectin expression in mesangial cells. Diabetologia. 2003;46(6):852–855.
   PubMed Web of Science ®Google Scholar
• Zeglinski MR, Hnatowich M, Jassal DS, et al. SnoN as a novel negative regulator of TGF-beta/Smad signaling: a target for tailoring organ fibrosis. Am J Physiol Heart Circ Physiol. 2015;308(2):H75–82.
   PubMed Web of Science ®Google Scholar
• Yf D, Yr P, Li J, et al. Gualou xiebai decoction prevents myocardial fibrosis by blocking TGF-beta/Smad signalling. J Pharm Pharmacol. 2013;65(9):1373–1381.
   PubMed Web of Science ®Google Scholar
• Liu JC, Zhou L, Wang F, et al. Osthole decreases collagen I/III contents and their ratio in TGF-beta1-overexpressed mouse cardiac fibroblasts through regulating the TGF-beta/Smad signaling pathway. Chin J Nat Med. 2018;16(5):321–329.
   PubMed Web of Science ®Google Scholar
• Zhu JN, Chen R, Fu YH, et al. Smad3 inactivation and MiR-29b upregulation mediate the effect of carvedilol on attenuating the acute myocardium infarction-induced myocardial fibrosis in rat. PLoS One. 2013;8(9):e75557.
   PubMed Web of Science ®Google Scholar